Because it hasn't been released as an ASX announcement (LINK), seems to have been released as a worldwide media news release (LINK). Not sure why, would have thought an ASX/US price sensitive announcement with a media release at the same time was the way to go. Anyway, I guess the people responsible know what they're doing.
Also, noted this in the news release:
"HEMGENIX is still currently under assessment by other regulatory agencies."
I'm assuming this means other countries, so more to come in the way of revenue.
And:
LINK
News: CSL CSL Behring Will Begin Commercializing Hemgenix Immediately In The U.S. With A List Price..., page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$255.51 |
Change
-1.870(0.73%) |
Mkt cap ! $123.5B | |||
| Open | High | Low | Value | Volume |
| $256.32 | $256.50 | $252.60 | $120.7M | 474.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 28 | $255.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $255.52 | 190 | 7 |
View Market Depth
| Last trade - 15.46pm 21/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |